tcsc0043319 GSK2200150A

GSK2200150A, identified by high-throughput screening (HTS) campaign, is an anti-tuberculosis (TB) agent.

IC50 & Target: MIC: 0.38 μM (M.tuberculosis strain H37Rv)^[1]

In Vitro: GSK2200150A is a novel antimycobacterial agent against Mycobacterium tuberculosis.The activities of GSK2200150A containing the spirocycle core are determined against the virulent M.tuberculosis strain (H37Rv) with MIC of 0.38 μM^[1].